USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/4666
Title: Utilizarea procalcitoninei test rapid semi cantitativ ca marker în boala inflamatorie pelvină acută
Other Titles: The use of Procalcitonin Semi Q in acute pelvic inflammatory disease
Authors: Cauş, Cătălin
Issue Date: 2011
Publisher: CEP Medicina
Citation: CAUŞ, Cătălin. Utilizarea procalcitoninei test rapid semi cantitativ ca marker în boala inflamatorie pelvină acută. In: Anale ştiinţifice ale USMF “Nicolae Testemiţanu”. Ed. a 12-a. Chişinau: СEP Medicina, 2011, vol. 5: Probleme actuale ale sănătăţii mamei si copilului, pp.152-155.
Abstract: Acute pelvic inflammatory disease is defined as an ascending infection of the upper genital tract leading to infection of the endometrium, fallopian tubes, ovaries and peritoneum. Acute PID is an ill understood, inaccurately diagnosed inadequately treated condition. This often leads to potentially serious squeal such as disseminated infection, infertility, ectopic pregnancy, increased risk of reinfection and chronic pelvic pain. Diagnostic difficulties of acute PID are compounded by the wide variety of clinical presentation. Early diagnosis and appropriate therapy of PID is a daily challenge for doctors. Other diagnostic modalities beside clinical signs and symptoms include: C reactive protein and erythrocyte sedimentation rate, both these tests have been extensively studied and seem to do equally well in term of sensitivity and specificity. Among the newest markers for evaluation of severity , procalcitonin has the highest diagnostic accuracy. Procalcitonin levels rise rapidly after infectious insult with systemic consequences. Daily changes of plasma PCT levels can give an indication of the course of the disease and the prognosis of the septics complications. The priorities in combating pelvic inflammatory disease is to identify the high risk population, educated them find cost effective diagnostic tests. Research needs to address speedy and early diagnosis on an outpatient basis and to identify women who are greatest risk of developing the squeal of pelvic inflammatory disease. Keywords: Procalcitonin (PCT), Pelvic Inflammatory Disease (PID/BIP), PCR Boala inflamatorie pelvină reprezintă cea mai frecventă cauza de adresare a pacinetelor în cabinetele ginecologice, la medicii de familie şi în serviciile de ginecologie.Boala Inflamatorie Pelvină este o infecţie frecventă unde fiziopatologia rămine puţin cunoscută, întâlnită în 44-65% la femei pâna 25 ani din care 1/3 înainte de 20 ani, la nulipare între 50-75% din cazuri, cu pariteneri multipli, ce poate aparea în perioada de menstra care se explica prin lipsa glerei cervicale în prezenţa sângelui - un mediu excelent de cultură pentru bacterii.
URI: http://repository.usmf.md/handle/20.500.12710/4666
Appears in Collections:Obstetrică și ginecologie

Files in This Item:
File Description SizeFormat 
UTILIZAREA_PROCALCITONINEI_TEST_RAPID_SEMI_CANTITATIV_CA_MARKER.pdf156.23 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback